Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Aurora Cannabis

Canopy Growth

Cannabis stocks are climbing ahead of the German legalization date this Monday, April 1. Indeed, many of the biggest marijuana companies have soared as the country's long-awaited weed decriminalization process comes full circle.

Cannabis Stocks Heat Up Again Ahead of German Rollout

Cannabis stocks are continuing their recent rally, as legalization support continues to build in the U.S and overseas.

2 Cannabis Stocks to Watch Amid Germany Legalization

BEND, Ore., March 26, 2024 (GLOBE NEWSWIRE) -- 10 Barrel Brewing Co. (“10 Barrel”), an award-winning pioneer in the craft brewing industry and a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is thrilled to introduce its latest innovations in the world of ready-to-drink canned cocktails: Disco Lemonade and AMF. These spirited concoctions mark a bold expansion of 10 Barrel's esteemed lineup of RTD cocktails, bringing a high-octane infusion of flavor and fun to the party scene.

10 Barrel Brewing Unveils Newest Ready-to-Drink Canned Cocktails

Desktop Metal

iRobot

As measured by the S&P 500, U.S. equities are up a solid 10% since January 1st; one segment hasn't yet caught up to the running bull market: the penny stock sector. The Russell 2000, a reasonable proxy for penny stocks to buy, returned just under 3% over the same period — but that may soon change.

3 Penny Stocks to Buy for the Next Bull Run: March 2024

Tilray Brands has a global footprint, and plenty of growth to come. Profitability will be a challenge for a while longer at a minimum.

Is Tilray Brands Stock a Millionaire Maker?

SNDL Inc.

The coming legalization of marijuana in Germany should give a lift to pot stocks like Canopy Growth (NYSE: CGC ), Tilray (NASDAQ: TLRY ), Cronos (NASDAQ: CRON ), SNDL (NASDAQ: SNDL ) and Aurora Cannabis (NASDAQ: ACB ). So far, however, investors are facing a bad trip.

Cannabis Stocks CGC, ACB, TLRY, SNDL Already Fading Despite German Legalization

Cannabis stocks are surging, helped by positive regulatory steps in the United States. Tilray Brands (NASDAQ: TLRY) stock jumped to $2.4 in the pre-market, its highest level since January 9th of this year.

Tilray and Aurora Cannabis stocks are flying but it's risky to buy

Cannabis stocks were a bubble that exploded in 2021. The hype associated with anxious states legalizing cannabis and hopes for the federal repeal of marijuana legislation has lost momentum, but it may be starting up again.

2 Cannabis Stocks Clawing Back from the Grave, Germany Legalizes

Cronos Group

Cannabis stocks are absolutely ripping higher today. A range of Canada-based cannabis companies, including Canopy Growth (NASDAQ: CGC ), Tilray (NASDAQ: TLRY ) and Cronos (NASDAQ: CRON ) are up more than 7% in today's session, with Canopy Growth leading the way with a gain of almost 60%.

Dear Cannabis Stocks Fans, Mark Your Calendars for April 1

The cannabis sector as a whole is getting a big boost today from news that Germany has approved partial cannabis legalization legislation. This law, expected to go into effect on April 1, has Tilray (NASDAQ: TLRY ) and a number of other cannabis producers surging.

TLRY Stock Alert: Tilray Just Got a Germany-Sized Boost

AdvisorShares Pure US Cannabis ETF

Canopy Growth led a weed stock rally early Friday after Germany legalized cannabis. New laws go into effect on April 1.

Canopy Growth, Weed Stocks Rocket After Germany Legalizes Cannabis

Vice President Kamala Harris endorsed marijuana legalization earlier this week, sending marijuana stocks flying higher. On Friday, marijuana investors got even better news: Germany will legalize weed on Easter Monday.

Why Tilray, Cronos, and Canopy Growth Stocks All Popped Today

Tilray faces huge obstacles in the cannabis market. The company's financial results leave much to be desired.

Can Tilray Stock Hit $3 in 2024?

Bitfarms Ltd

IAMGOLD

Meme stocks can be likened to altcoins in terms of volatility and the ferocity of price action. Getting into the right meme stock can potentially imply multibagger returns in a matter of months.

3 Meme Stocks That Could Double Your Money in Just 3 Months

CoreCivic

Deere & Company

Kratos Defense & Security Solutions

Sturm, Ruger & Company

Vulcan Materials

Exxon Mobil

While political cycles are always difficult to predict, the challenge of finding stocks for the presidential election is slightly easier. How can that be, you might wonder?

7 Stocks to Own in the Run-Up to the Presidential Election

Cannabis stocks cooled off Thursday but held onto big gains from the past week on the heels of positive comments from the Biden administration on reclassifying cannabis from a Schedule I controlled substance under federal law.

Cannabis stocks fall but hold onto big gains from the week on brighter federal reform prospects

Redecan Announces New Space Age Cake Flower and Hemp'd Pre-rolls, Plus its New Taster Series Coming Soon, Featuring A Variety Pack Of Its Signature Redees.

Redecan Cannabis Launches New Spring Lineup

Village Farms International

As we turn our attention to the Canadian cannabis sector and top marijuana stocks this week, it's hard not to notice the buzz it's creating among investors. With Canada leading the charge in legalizing cannabis for both medical and recreational use, its companies are now at the heart of a growing global market. This makes Canadian cannabis stocks particularly interesting to watch. They're not just a reflection of the thriving market at home; they symbolize Canada's prominent role on the world stage. The excitement is palpable as investors keep their eyes peeled for signs of growth and strategic international moves. Keeping up with market trends, regulatory shifts, and the competitive landscape is key to staying ahead.

Canadian Cannabis Stocks to Watch in Mid-March 2024

Scotts Miracle-Gro

While it's difficult to say with confidence who will win out in the elections later this year, investors of cannabis stocks may have something to look forward to. Basically, the attention should turn not to a possible red or blue wave but rather a green one.

3 Cannabis Stocks Ready to Light Up on Reform Rumors

Cannabis stocks surged Monday after Vice President Kamala Harris called on the Drug Enforcement Administration (DEA) to reschedule marijuana “as quickly as possible.” Cannabis is currently a Schedule 1 narcotic, the same classification as heroin, a point Harris called “absurd” and “patently unfair.

Why Are Cannabis Stocks TLRY, ACB, CGC, SNDL Up Today?

Cannabis stocks moved higher after US Vice President Kamala Harris on Friday urged the Drug Enforcement Administration (DEA) to reschedule marijuana as a lower-risk drug “as quickly as possible.” Harris, at a White House meeting with individuals who have received marijuana pardons from the Biden administration, said that it was “absurd” and “patently unfair” that marijuana remains in the same drug category as heroin and is considered more dangerous than fentanyl.

Cannabis stocks rally as VP Harris calls on DEA to reschedule marijuana ‘as quickly as possible'

Tilray (NASDAQ: TLRY ) stock is rising higher on Monday as investors celebrate the company securing approval for the first medical cannabis extract in Portugal. This is a major win for TLRY stockholders and shows that the company is making headway in the country.

Why Is Tilray (TLRY) Stock Up Today?

Tilray Brands (NASDAQ: TLRY) stock price is struggling this year. It has already plunged by more than 24% in 2024, underperforming the Nasdaq 100, Dow Jones, and S&P 500 indices that have surged to their highest level on record.

Tilray Brands stock forecast: taking the rebound with a grain of salt

Diageo

Kirin Holdings Co Ltd

St. Patrick's Day is upon us and investors feeling lucky might be looking to undervalued craft beer stocks to diversify their portfolios. Though global beer markets remain frothy, with sales falling 3% in recent years, craft beer sales are expanding and jumped 6% over the same period.

The 3 Most Undervalued Craft Beer Stocks to Buy in March 2024

Coupang

Lithium Americas Corp

Li Auto Inc.

MINISO Group Holding

Riot Blockchain

Hypergrowth stocks provide some exciting opportunities for quick returns. Because growth stocks have a high-beta, opportunities are created in a correction or when the growth story faces near term headwinds.

Hypergrowth Hitlist: 7 Stocks Primed to Skyrocket 100% in the Next 9 Months

News for Tilray Brands Stock (TLRY)